<DOC>
	<DOCNO>NCT00719823</DOCNO>
	<brief_summary>The objective study provide Maraviroc compassionate use basis antiretroviral treatment experience patient infected CCR5-tropic HIV-1 urgent unmet medical need , opinion physician , require Maraviroc form viable regimen .</brief_summary>
	<brief_title>Maraviroc Compassionate Use</brief_title>
	<detailed_description>This study cancel prior enrollment .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Maraviroc</mesh_term>
	<criteria>Patients least 16 year old prior extensive treatment experience limit option need maraviroc constitute effective HIV1 treatment regimen . Have CCR5tropic HIV1 virus CD4+ cell count &lt; 200 cells/mm3 CXCR4 dual/mixedtropic HIV1 virus Patients opinion investigator unlikely derive benefit maraviroc result severity illness Patients pregnant breast feeding infant planning become pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Maraviroc Compassionate Use</keyword>
</DOC>